Tanner Pharma Group and ExeGi Pharma Announce Partnership to Distribute High Potency Probiotic in Mexico to Support Patients with Gut Microbiome Imbalance

Rockville, M.D., and Charlotte, N.C., April 12, 2023 – ExeGi Pharma LLC (“ExeGi”), a leading developer of live biotherapeutic drugs and probiotics, has announced a partnership with TannerLAC, Inc. (“TannerLAC”), a division of Tanner Pharma Group, to distribute Visbiome® in Mexico. Visbiome® is a high-potency probiotic medical food that helps manage dysbiosis associated with medical conditions like irritable bowel syndrome and ulcerative colitis. With eight probiotic strains delivered in high potency, Visbiome® is one of the most extensively researched probiotics on the market, with over 80 human clinical trials performed over the last 20 years. The formulation is available in more than 40 countries.

TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner for the commercialization of their products in challenging international markets. Under the license agreement, Tanner will register, commercialize, and promote Visbiome® initially in Mexico, with plans to expand to other Latin American countries.

“Years ago, I witnessed firsthand how Visbiome® transformed the lives of two people close to me,” said Carolina Cortez, EVP of TannerLAC. “Today, we are thrilled to partner with ExeGi and begin our journey in Mexico. We are confident that Visbiome® will be a valuable addition to our portfolio and will enable patients in Mexico to finally access this potent probiotic that has proven to support individuals with various digestive conditions.”

“We are excited to collaborate with Tanner to make Visbiome® accessible to patients in Mexico,” said Marc Tewey, ExeGi’s CEO. “The Tanner team is ideally suited to manage the regulatory and commercial requirements for distributing our product to our Mexican neighbors.”

To learn more about Visbiome®, please visit www.visbiome.com.

About ExeGi Pharma

ExeGi Pharma LLC is a biotechnology company focused on developing and commercializing live biotherapeutic and probiotic medicines. Our purpose is to formulate the most effective probiotics and live biotherapeutics to provide relief from serious conditions so people, and their pets, may live healthier lives. ExeGi is headquartered in Rockville, MD. For more information, please visit www.exegipharma.com.

About Tanner Pharma Group Tanner Pharma Group is a specialist pharmaceutical partner focused on improving global access to medicines. By partnering with Tanner Pharma, companies can focus on their primary markets while ensuring that patients and clinicians in international markets can also benefit from using their products. Tanner Pharma has a global reach and provides international commercialization and patient access through product registration and licensing, managed and global access programs and clinical trial solutions. For more information, please visit www.tannerpharma.com.

For further information, please contact:

ExeGi Pharma

Claudia Ortiz

E: Claudia.Ortiz@exegipharma.com

T: 844-348-4887

Tanner Pharma Group – TannerLAC

Adriana Alves De Freitas

E: aalves@tannerpharma.com 

T: +1 (980) 867 4350

Tanner Pharma Group – Communications

Lindsey Stevens

E: lstevens@tannerpharma.com

T: +1 (704) 552-8408

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.